AIVA Care

2026-04-20

Follow-up

Scheduled: CBC + BMA if indicated

2026-03-28

Surveillance

WBC 4,200 ANC 2,100 Hb 10.5 Plt 145K Blasts 0%

Midostaurin 50mg BID Acyclovir 400mg BID TMP-SMX MWF

MRD by flow: Negative | Midostaurin cycle 4/12

2026-02-15

Post-Consolidation

Started Midostaurin 50mg BID

BMA: Complete Remission, MRD negative
FLT3-ITD: Not detected
Started maintenance: Midostaurin 12 cycles

2026-01-10

HiDAC #3

WBC 200 Plt 12K

Cytarabine 3g/m² q12h × 6 doses
Febrile neutropenia → Meropenem

2025-11-25

HiDAC #2

Cytarabine 3g/m² q12h × 6 doses

2025-10-15

HiDAC #1

Cytarabine 3g/m² q12h × 6 doses

2025-09-01

Induction 7+3 + Midostaurin

Cytarabine 200mg/m²/day × 7d + Daunorubicin 60mg/m²/day × 3d
+ Midostaurin 50mg BID day 8-21 (RATIFY protocol)
Day 14 BMA: Hypocellular, no blasts
Day 28: Complete Remission achieved

General User

Leukemia Patient

Patient Login

My Treatment Journey

My Health Overview

Physician

Last Labs (Mar 28, 2026)

Current Medications